In yesterday’s post, we introduced and began reviewing the recent report submitted to Congress by the SEC. It provides helpful details and insight into the whistleblower program advanced by the Dodd Frank Act as well as an analysis of fiscal year 2013 and the highlights therein, including a record-breaking $14 […]
As we reported last week, the Dodd-Frank Wall Street Reform and Consumer Protection Act has been highly integral in protecting investors and taxpayers as well as holding fraudulent investors and corporate managers responsible for their misdeeds. Earlier this month, the Securities Exchange Commission, an entity responsible for overseeing the securities […]
Our blog often discusses litigation surrounding the False Claims Act, which is the hallmark whistleblower statute in the United States. Enacted during the Civil War, the FCA and its incentivizing qui tam provisions paved the way for other government entities to advocate for Congress to enact similar provisions in their […]
According to the Department of Health and Human Services, the federal anti-kickback statute serves one purpose: to protect patients and the federal health care programs from fraud and abuse by curtailing the corrupting influence of money on health care decisions. As we have reported in the past, this law has proven […]
In yet another case of unlawful Medicare billing, Vantage Oncology Center has agreed to pay $2 million to settle allegations it defrauded federal healthcare entities including Medicare and Medicaid. This case comes on the heels of a recent mega-settlement by neighbor Omnicare, Inc., a pharmacy services company alleged to have […]